Scott Halstead
#56,902
Most Influential Person Now
Researcher ORCID ID = 0000-0002-7818-348X
Scott Halstead's AcademicInfluence.com Rankings
Scott Halsteadmedical Degrees
Medical
#497
World Rank
#675
Historical Rank
Public Health
#63
World Rank
#64
Historical Rank
Scott Halsteadphilosophy Degrees
Philosophy
#2714
World Rank
#4544
Historical Rank
Logic
#737
World Rank
#1259
Historical Rank
Download Badge
Medical Philosophy
Scott Halstead's Degrees
- Doctorate Medicine University of California, San Francisco
Why Is Scott Halstead Influential?
(Suggest an Edit or Addition)According to Wikipedia, Scott Halstead is an American physician-scientist, virologist and epidemiologist known for his work in the fields of tropical medicine and vaccine development. He is considered one of the world's foremost authorities on viruses transmitted by mosquitoes, including Dengue, Japanese encephalitis, chikungunya and Zika. He was one of the first researchers to identify the phenomenon known as antibody-dependent enhancement , where the antibodies generated from a first dengue infection can sometimes worsen the symptoms from a second infection.
Scott Halstead's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Dengue: a continuing global threat (2010) (1829)
- Pathogenesis of dengue: challenges to molecular biology. (1988) (1626)
- Neutralization and antibody-dependent enhancement of dengue viruses. (2003) (717)
- Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. (1984) (708)
- Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered. (1970) (564)
- Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection (2013) (556)
- Antibody-enhanced dengue virus infection in primate leukocytes (1977) (543)
- Evaluation of diagnostic tests: dengue (2010) (500)
- Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade. (1989) (460)
- In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. (1979) (444)
- Dengue and chikungunya virus infection in man in Thailand, 1962-1964. I. Observations on hospitalized patients with hemorrhagic fever. (1969) (422)
- Dengue virus-mosquito interactions. (2008) (420)
- Dengue haemorrhagic fever--a public health problem and a field for research. (1980) (396)
- Cost of dengue cases in eight countries in the Americas and Asia: a prospective study. (2009) (383)
- Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes (2010) (372)
- Observations related to pathogensis of dengue hemorrhagic fever. VI. Hypotheses and discussion. (1970) (368)
- Dengue infection (2016) (353)
- Epidemiologic studies on Dengue in Santiago de Cuba, 1997. (2000) (318)
- Effect of age on outcome of secondary dengue 2 infections. (2002) (315)
- Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles. (2004) (308)
- Selective primary health care: strategies for control of disease in the developing world. XI. Dengue. (1984) (304)
- Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic fever (1999) (302)
- Dengue and chikungunya virus infection in man in Thailand, 1962-1964. IV. Epidemiologic studies in the Bangkok metropolitan area. (1969) (301)
- Original antigenic sin in dengue. (1983) (276)
- Simplified plaque reduction neutralization assay for dengue viruses by semimicro methods in BHK-21 cells: comparison of the BHK suspension test with standard plaque reduction neutralization (1985) (253)
- Dengue Hemorrhagic Fever in Infants: Research Opportunities Ignored (2002) (253)
- Enhanced severity of secondary dengue-2 infections: death rates in 1981 and 1997 Cuban outbreaks. (2002) (236)
- Dengue in the Americas and Southeast Asia: do they differ? (2006) (233)
- Evaluation of Commercially Available Anti–Dengue Virus Immunoglobulin M Tests (2009) (231)
- Dengue Antibody-Dependent Enhancement: Knowns and Unknowns. (2014) (228)
- A prospective seroepidemiologic study on dengue in children four to nine years of age in Yogyakarta, Indonesia I. studies in 1995-1996. (1999) (224)
- Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control study (1996) (218)
- Haiti: absence of dengue hemorrhagic fever despite hyperendemic dengue virus transmission. (2001) (216)
- Immune enhancement of viral infection. (1982) (213)
- Best Practices in Dengue Surveillance: A Report from the Asia-Pacific and Americas Dengue Prevention Boards (2010) (212)
- In-Depth Analysis of the Antibody Response of Individuals Exposed to Primary Dengue Virus Infection (2011) (207)
- Good health at low cost. (1985) (204)
- Rubella: reinfection of vaccinated and naturally immune persons exposed in an epidemic. (1970) (197)
- The XXth century dengue pandemic: need for surveillance and research. (1992) (188)
- Japanese encephalitis vaccines. (2006) (184)
- Immunological enhancement of dengue virus replication. (1973) (177)
- Studies on the pathogenesis of dengue infection in monkeys. II. Clinical laboratory responses to heterologous infection. (1973) (174)
- Cost-effectiveness of a pediatric dengue vaccine. (2004) (167)
- The Alexander D. Langmuir Lecture. The pathogenesis of dengue. Molecular epidemiology in infectious disease. (1981) (167)
- Natural history of dengue virus (DENV)-1 and DENV-4 infections: reanalysis of classic studies. (2007) (167)
- Studies on the pathogenesis of dengue infection in monkeys. I. Clinical laboratory responses to primary infection. (1973) (161)
- Effect of dengue-1 antibodies on American dengue-2 viral infection and dengue haemorrhagic fever (2002) (160)
- Reappearance of Chikungunya, Formerly Called Dengue, in the Americas (2015) (158)
- Enhancement of dengue virus infection in monocytes by flavivirus antisera. (1980) (154)
- 5 – Immunological Parameters of Togavirus Disease Syndromes (1980) (151)
- The future of dengue vaccines (2002) (151)
- Efficacy of single-dose SA 14–14–2 vaccine against Japanese encephalitis: a case control study (2001) (149)
- Evaluation of Commercially Available Diagnostic Tests for the Detection of Dengue Virus NS1 Antigen and Anti-Dengue Virus IgM Antibody (2014) (146)
- Protective and immunological behavior of chimeric yellow fever dengue vaccine. (2016) (143)
- Dengvaxia sensitizes seronegatives to vaccine enhanced disease regardless of age. (2017) (143)
- Dengue hemorrhagic Fever caused by sequential dengue 1-3 virus infections over a long time interval: Havana epidemic, 2001-2002. (2006) (143)
- The Impact of the Newly Licensed Dengue Vaccine in Endemic Countries (2016) (141)
- Pathologic highlights of dengue hemorrhagic fever in 13 autopsy cases from Myanmar. (2014) (137)
- How Innate Immune Mechanisms Contribute to Antibody-Enhanced Viral Infections (2010) (134)
- Association between sex, nutritional status, severity of dengue hemorrhagic fever, and immune status in infants with dengue hemorrhagic fever. (2005) (131)
- Mosquito-borne haemorrhagic fevers of South and South-East Asia. (1966) (127)
- Etiologies of the experimental dengues of Siler and Simmons. (1974) (127)
- Measurement of antibody-dependent infection enhancement of four dengue virus serotypes by monoclonal and polyclonal antibodies. (1990) (124)
- Heterogeneity of infection enhancement of dengue 2 strains by monoclonal antibodies. (1984) (124)
- Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: a case-control study in Nepalese children 5 years after immunization. drjbtandan@yahoo.com. (2007) (122)
- Dengue vaccine development: a 75% solution? (2012) (119)
- New Japanese encephalitis vaccines: alternatives to production in mouse brain (2011) (116)
- Studies on the pathogenesis of dengue infection in monkeys. 3. Sequential distribution of virus in primary and heterologous infections. (1973) (116)
- Neutralizing Antibodies after Infection with Dengue 1 Virus (2007) (116)
- Dengue d chikungunya virus infection in man in Thailand, 1962-1964. II. Observations on disease in outpatients. (1969) (115)
- Identifying protective dengue vaccines: guide to mastering an empirical process. (2013) (112)
- Observations related to pathogenesis of dengue hemorrhagic fever. 3. Virologic studies of fatal disease. (1970) (112)
- Observations related to the pathogenesis of dengue hemorrhagic fever. II. Antigenic and biologic properties of dengue viruses and their association with disease response in the host. (1970) (109)
- Effect of single dose of SA 14-14-2 vaccine 1 year after immunisation in Nepalese children with Japanese encephalitis: a case-control study (2005) (102)
- Dengue virus: molecular basis of cell entry and pathogenesis, 25-27 June 2003, Vienna, Austria. (2005) (102)
- Shock associated with dengue infection. I. Clinical and physiologic manifestations of dengue hemorrhagic fever in Thailand, 1964. (1966) (102)
- Short-term safety of live attenuated Japanese encephalitis vaccine (SA14-14-2): results of a randomized trial with 26,239 subjects. (1997) (99)
- Summary report: workshop on the potential risks of antibody-dependent enhancement in human HIV vaccine trials. (1993) (99)
- Approaches to Refining Estimates of Global Burden and Economics of Dengue (2014) (98)
- Controlling Dengue with Vaccines in Thailand (2012) (96)
- Observations related to pathogenesis of dengue hemorrhagic fever. V. Examination of agspecific sequential infection rates using a mathematical model. (1970) (91)
- Economic and Disease Burden of Dengue in Mexico (2015) (89)
- The risks behind Dengvaxia recommendation. (2016) (88)
- Subclinical Japanese encephalitis. I. Infection of Americans with limited residence in Korea. (1962) (88)
- Do escape mutants explain rapid increases in dengue casefatality rates within epidemics? (2000) (87)
- Antibodies Determine Virulence in Dengue (2009) (85)
- Global epidemiology of dengue hemorrhagic fever. (1990) (85)
- High-Avidity and Potently Neutralizing Cross-Reactive Human Monoclonal Antibodies Derived from Secondary Dengue Virus Infection (2013) (85)
- Hemorrhagic fever in Thailand; recent knowledge regarding etiology. (1967) (81)
- Dengue and chikungunya virus infection in man in Thailand, 1962-1964. V. Epidemiologic observations outside Bangkok. (1969) (81)
- Good health at low cost : Proceedings of a conference held at the Bellagio Conference Cente [,] Bellagio, Italy : April 29 - May 3, 1985 : Sponsored by The Rockefeller Foundation (1985) (79)
- Dengue chikungunya virus infection in man in Thailand, 1962-1964. 3. Clinical, epidemiologic, and virologic observations on disease in non-indigenous white persons. (1969) (78)
- Observations related to pathogenesis of dengue hemorrhagic fever. I. Experience with classification of dengue viruses. (1970) (77)
- The burden of dengue infection (2007) (77)
- Controversies in dengue pathogenesis (2012) (76)
- Transmission of dengue 1 and 2 viruses in Greece in 1928. (1980) (75)
- Is there an inapparent dengue explosion? (1999) (74)
- Japanese encephalitis: new options for active immunization. (2010) (73)
- Antibody response in dengue and dengue hemorrhagic fever. (1967) (72)
- Severe dengue in travellers: pathogenesis, risk and clinical management. (2019) (71)
- Virus evolution during a severe dengue epidemic in Cuba, 1997. (2005) (69)
- Biologic properties of dengue viruses following serial passage in primary dog kidney cells: studies at the University of Hawaii. (2003) (69)
- Dengue Hemorrhagic Fever at 60 Years: Early Evolution of Concepts of Causation and Treatment (2015) (66)
- Pathogenesis of Dengue: Dawn of a New Era (2015) (65)
- Profiles of antibody-dependent enhancement of dengue virus type 2 infection. (1987) (64)
- Studies on the immunization of monkeys against dengue. I. Protection derived from single and sequential virus infections. (1973) (62)
- Growth of dengue type 2 virus isolates in human peripheral blood leukocytes correlates with severe and mild dengue disease. (1991) (62)
- Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. V. Human response to immunization with a candidate vaccine prepared in fetal rhesus lung cells. (1984) (62)
- Dengue and dengue hemorrhagic fever (1990) (61)
- Infections with two dengue viruses in Greece in the 20th century. Did dengue hemorrhagic fever occur in the 1928 epidemic? (1977) (60)
- Dengue Virus Replication Enhancement in Peripheral Blood Leukocytes from Immune Human Beings 1 (1976) (59)
- The Wages of Original Antigenic Sin (2010) (58)
- More Dengue, More Questions (2005) (58)
- Cross-infection enhancement among African flaviviruses by immune mouse ascitic fluids. (1987) (54)
- RECENT EPIDEMICS OF HEMORRHAGIC FEVER IN THAILAND. OBSERVATIONS RELATED TO PATHOGENESIS OF A "NEW" DENGUE DISEASE. (1965) (54)
- Dengue 4 virus monoclonal antibodies identify epitopes that mediate immune infection enhancement of dengue 2 viruses. (1987) (53)
- Safety issues from a Phase 3 clinical trial of a live-attenuated chimeric yellow fever tetravalent dengue vaccine (2018) (53)
- Dengue and hemorrhagic fevers of Southeast Asia. (1965) (53)
- The International Clinical Epidemiology Network (INCLEN): a progress report. (1991) (51)
- Specific lethality of silica for human peripheral blood mononuclear phagocytes, in vitro. (1978) (51)
- Critique of World Health Organization Recommendation of a Dengue Vaccine. (2016) (51)
- Rubella antibody persistence after immunization. (1982) (50)
- Inhibition of dengue virus replication by amantadine hydrochloride (1980) (50)
- COVID 19 Vaccines: Should we fear ADE? (2020) (49)
- Dengue Virus Type 3, Cuba, 2000–2002 (2005) (47)
- Biologic Evidence Required for Zika Disease Enhancement by Dengue Antibodies (2017) (46)
- Immunogenicity of live attenuated SA14-14-2 Japanese encephalitis vaccine--a comparison of 1- and 3-month immunization schedules. (1998) (45)
- Dengue: The Syndromic Basis to Pathogenesis Research. Inutility of the 2009 WHO Case Definition (2013) (44)
- Studies of bladder stone disease in Thailand. I. Introduction and description of area studied. (1967) (44)
- Dengue: Overview and History (2008) (44)
- Viral kinetics of primary dengue virus infection in non-human primates: a systematic review and individual pooled analysis. (2014) (43)
- Comparison of P388D1 mouse macrophage cell line and human monocytes for assay of dengue-2 infection-enhancing antibodies. (1983) (43)
- Licensed Dengue Vaccine: Public Health Conundrum and Scientific Challenge (2016) (42)
- Volume replacement in infants with dengue hemorrhagic fever/dengue shock syndrome. (2006) (42)
- Recombination and flavivirus vaccines: a commentary. (2005) (41)
- Dengue hemorrhagic fever: two infections and antibody dependent enhancement, a brief history and personal memoir. (2002) (41)
- Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. III. Reversion to virulence by passage of cloned virus in fetal rhesus lung cells. (1984) (40)
- Human antibody to dengue soluble complement-fixing (SCF) antigens. (1973) (40)
- Booster vaccination with further live attenuated measles vaccine. (1976) (39)
- Assessing the Potential of a Candidate Dengue Vaccine with Mathematical Modeling (2012) (39)
- Consider stopping dengvaxia administration without immunological screening (2017) (38)
- Studies on the immunization of monkeys against dengue. II. Protection following inoculation of combinations of viruses. (1973) (37)
- Treatment of intracranial dengue virus infections in mice with a lipophilic derivative of ribavirin (1983) (37)
- Tissue culture techniques for the study of dengue viruses. (1966) (37)
- Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination? There Is Only One True Winner. (2018) (36)
- Japanese encephalitis vaccines. (1998) (36)
- 25 Antibody-dependent Enhancement of Infection: A Mechanism for Indirect Virus Entry into Cells (1994) (35)
- Rubella in an immunized island population. (1973) (35)
- Dengue hemorrhagic fever in South Vietnam: report of the 1963 outbreak. (1965) (35)
- Recent advances in understanding dengue (2019) (34)
- Japanese encephalitis. (2003) (34)
- STUDIES OF HEMOSTASIS IN THAI HEMORRHAGIC FEVER. (1965) (33)
- Disease severity‐related antigenic differences in dengue 2 strains detected by dengue 4 monoclonal antibodies (1987) (33)
- Virus role during intraepidemic increase in dengue disease severity. (2011) (33)
- Accelerating the development and introduction of a dengue vaccine for poor children, 5-8 December 2001, Ho Chi Minh City, VietNam. (2002) (33)
- An explanation for enhanced virus plaque formation in chick embryo cells (1980) (32)
- Dengue virus type 2 in Cuba, 1997: conservation of E gene sequence in isolates obtained at different times during the epidemic (2005) (32)
- Ethics of a partially effective dengue vaccine: Lessons from the Philippines (2020) (31)
- Clinical and laboratory studies on haemorrhagic fever in Burma, 1970-72. (1974) (31)
- Serological response to rubella revaccination. (1984) (31)
- Replication of dengue viruses in cultures of peripheral blood leukocytes from dengue-immune rhesus monkeys. (1976) (31)
- Epidemiological studies on dengue virus type 3 in Playa municipality, Havana, Cuba, 2001-2002. (2012) (30)
- Global Epidemiology of Dengue : Health Systems in Disarray (1994) (30)
- Achieving safe, effective, and durable Zika virus vaccines: lessons from dengue. (2017) (30)
- Studies of bladder stone disease in Thailand. 3. Epidemiologic studies in Ubol Province. (1967) (30)
- Assay of Mouse Adapted Dengue Viruses in Mammalian Cell Cultures by An Interference Method (1964) (28)
- Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. IV. Characterization of a vaccine candidate in fetal rhesus lung cells. (1984) (28)
- Hemorrhagic fevers of Southeast Asia and South America: a comparative appraisal. (1967) (28)
- Studies of bladder stone disease in Thailand. IV. Dietary habits, nutritional intake, and infant feeding practices among residents of a hypo- and hyperendemic area. (1967) (27)
- Susceptibility of rubella among adolescents and adults in Hawaii. (1969) (27)
- Antiviral effects if ribavirin and 6-mercapto-9-tetrahydro-2-furylpurine against dengue viruses in vitro. (1982) (27)
- Dengue Viruses and Mononuclear Phagocytes (2003) (26)
- Rubella Immunization: Persistence of Antibody Four Years After a Large-Scale Field Trial (1976) (26)
- Dengue carrier culture and antigen production in human lymphoblastoid lines. (1975) (26)
- Studies of bladder stone disease in Thailand. VI. Urinary studies in children, 2-10 years old, resident in a hypo- and hyperendemic area. (1967) (25)
- Comparison of Dengue Virus Plaque Reduction Neutralization by Macro and ‘Semi‐Micro’ Methods in LLC‐MK2 Cells (1985) (25)
- Dengue 1 virus and dengue hemorrhagic fever, French Polynesia, 2001. (2009) (25)
- Study of the distribution of antibody‐ dependent enhancement determinants on dengue 2 isolates using dengue 2‐derived monoclonal antibodies (1987) (24)
- Heterologous flavivirus infection-enhancing antibodies in sera of Nigerians. (1988) (24)
- Call to Action for Dengue Vaccine Failure (2013) (24)
- A T164S mutation in the dengue virus NS1 protein is associated with greater disease severity in mice (2019) (23)
- Epidemiology of bladder stone of children: precipitating events (2016) (23)
- Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. I. Attributes of uncloned virus at different passage levels. (1984) (23)
- Dengue: hematologic aspects. (1982) (22)
- Studies of bladder stone disease in Thailand. II. Hospital experience. Urolithiasis at Ubol Provincial Hospital, 1956-1962. (1967) (22)
- Successes and Failures in Dengue Control - Global Experience * (2000) (21)
- Studies of bladder stone disease in Thailand. V. Dietary habits and disease prevalence. (1967) (21)
- A relevant in vitro human model for the study of Zika virus antibody-dependent enhancement. (2017) (21)
- Dengue infection and advances in dengue vaccines for children. (2019) (20)
- Dengue vascular permeability syndrome: what, no T cells? (2013) (20)
- Assessing the prognosis of dengue-infected patients (2009) (20)
- Is Dengvaxia a useful vaccine for dengue endemic areas? (2019) (20)
- Effect of immune status on dengue 2 virus replication in cultured leukocytes from infants and children (1979) (18)
- Use of the live attenuated Japanese Encephalitis vaccine SA 14–14–2 in children: A review of safety and tolerability studies (2017) (18)
- A lipid inhibitor of dengue virus in human colostrum and milk; with a note on the absence of anti-dengue secretory antibody (2005) (18)
- Dengue in the health transition. (1994) (18)
- STUDIES ON DENGUE VIRUS INFECTION. 1. IMMUNOFLUORESCENT LOCALIZATION OF VIRUS IN MOUSE TISSUE. (1964) (18)
- Aedes aegypti: why can't we control it? (1988) (17)
- Pathogenesis: Risk Factors Prior to Infection (2008) (17)
- Role of antibodies and host cells in plaque enhancement of Murray Valley encephalitis virus (1983) (17)
- Failure to transmit rubella virus vaccine. A close-contact study in adults. (1971) (17)
- Absence of dengue 2 infection enhancement in human sera containing Japanese encephalitis antibodies. (1984) (17)
- Global perspectives on dengue research. (2000) (16)
- Epidemiological studies of Thai haemorrhagic fever, 1962-64. (1966) (16)
- Oral polio vaccine. Effect of booster vaccination one to 14 years after primary series (1978) (15)
- Japanese encephalitis vaccine for travelers: risk-benefit reconsidered. (2019) (15)
- Vertebrate hosts of chikungunya virus. (1966) (15)
- Dengue vaccines: Are they safe for travelers? (2016) (15)
- In vitro Recovery of Dengue Viruses from Naturally Infected Human Beings and Arthropods (1964) (14)
- Suppression of dengue virus replication in vitro by rimantadine hydrochloride. (1981) (14)
- Incidence of infectious mononucleosis at the Universities of California and Hawaii. (1979) (14)
- Oral polio vaccine. Effect of booster vaccination one to 14 years after primary series. (1978) (14)
- Challenges to the Design of Clinical Trials for Live-Attenuated Tetravalent Dengue Vaccines (2016) (14)
- Evaluation of three rubella vaccines in adult women. (1970) (13)
- Zika enhancement: a reality check. (2017) (13)
- Nonspecific Factors in Monkey Tissues and Serum Causing Inhibition of Plaque Formation and Hemagglutination by Dengue Viruses (1971) (13)
- The Bangkok variant of the serum group-specific component (Gc) and the frequency of the Gc alleles in Thailand. (1968) (13)
- Ultrastructural studies on dengue virus infection of human lymphoblasts (1978) (13)
- Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. II. Attributes of virus cloned at different dog kidney passage levels. (1984) (13)
- Bladder stone in Thailand. A review of the problem. (1961) (12)
- SUBCLINICAL JAPANESE ENCEPHALITISANTIBODY RESPONSES OF AMERICANS TO SINGLE EXPOSURE TO JE VIRUS (1962) (12)
- Recovery of Japanese encephalitis virus from wild caught mosquitoes in Thailand. (1972) (12)
- COVID-19 and SARS Coronavirus 2: Antibodies for the Immediate Rescue and Recovery Phase (2020) (12)
- Vaccine-Associated Enhanced Viral Disease: Implications for Viral Vaccine Development (2021) (12)
- Recent virological studies on haemorrhagic fever and other arthropod-borne virus infections in the Philippines. (1966) (12)
- Cell-mediated immune response to respiratory syncytial virus infection in owl monkeys. (1983) (12)
- Hemorrhagic Disease in Rodents Infected with Virus Associated with Thai Hemorrhagic Fever (1961) (11)
- Travelling arboviruses: A historical perspective. (2019) (11)
- In vitro virulence marker: growth of dengue-2 virus in human leukocyte suspension cultures (1981) (11)
- Emergence Mechanisms in Yellow Fever and Dengue (1998) (10)
- Hemorrhagic Disease in Rodents Caused by Chikungunya Virus. 1. Studies of Hemostasis (1965) (9)
- Editorial response: Resuscitation of patients with dengue hemorrhagic fever/dengue shock syndrome. (1999) (9)
- Genetic risk for dengue hemorrhagic fever and dengue fever in multiple ancestries (2020) (9)
- Dengue Vaccine Efficacy: Not a Zero Sum Game. (2016) (9)
- New Vaccines for Japanese Encephalitis (2010) (9)
- Studies on dengue 2 virus infection in cyclophosphamide-treated rhesus monkeys (1980) (9)
- Dengue Fever and Dengue Hemorrhagic Fever (2011) (8)
- Serologic response to revaccination with two rubella vaccines. (1976) (8)
- ALIMENTARY HYPERSENSITIVITY INDUCED BY GIARDIA LAMBLIA; REPORT OF A CASE OF ACUTE MEAT INTOLERANCE. (1965) (8)
- Viral hemorrhagic fevers. (1981) (8)
- Immune Enhancement of Viral Infection (Part 1 of 3) (1982) (7)
- Measuring dengue enhancing antibodies: caveats. (2006) (7)
- Consultation on dengue vaccines: progress in understanding protection, 26-28 June 2013, Rockville, Maryland. (2014) (7)
- Tissue culture-based rabies vaccines: vaccine production technology transfer. (1988) (7)
- Pathogenic Exploitation of Fc Activity (2013) (7)
- Dengue-the case definition dilemma : A commentary (2007) (7)
- Phytohemagglutinin enhancement of dengue-2 virus replication in nonimmune rhesus monkey peripheral blood leukocytes (1978) (7)
- Dengue vaccine and the 2016 Olympics (2016) (7)
- Laboratory detection of arthropod-borne virus infection in the Philippines. (1966) (7)
- 44 – Dengue vaccines (2013) (7)
- The Control of Dengue Vectors (2008) (6)
- Correction: In-Depth Analysis of the Antibody Response of Individuals Exposed to Primary Dengue Virus Infection (2011) (5)
- Recovery of dengue viruses from tissues of experimentally infected rhesus monkeys. (1972) (5)
- Pharmacoepidemiology for developing countries (1990) (5)
- Insights from direct studies on human dengue infections (2018) (5)
- Summaries of Papers Presented at the WHO Inter-Regional Seminar on Mosquito-Borne Haemorrhagic Fevers in the South-East Asia and Western Pacific Regions, 1964: Identification of dengue and chikungunya viruses (1966) (5)
- Rubella vaccination: fertility control in a large-scale vaccination program for postpubertal women. (1975) (5)
- Predictors of dengue severity. (2016) (5)
- WHO fights dengue haemorrhagic fever. (1982) (5)
- Tropical viral infections. (1998) (5)
- The dengue situation in Singapore. (1998) (5)
- Antibody-mediated enhancement of Wesselsbron virus in P388D1 cells. (1986) (5)
- Faculty Opinions recommendation of Clinical characteristics of Dengue shock syndrome in Vietnamese children: a 10-year prospective study in a single hospital. (2014) (4)
- Comment on “Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity” and “Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination” (2015) (4)
- Recovery of dengue and other viruses in mice and tissue culture from Thai mosquitos. (1966) (4)
- T he impact of the newly licensed dengue vaccine in endemic (2016) (4)
- Cause of Primary Bladder Stone in England — A Retrospective Epidemiological Study (1981) (4)
- An Urgent Need for “Common Cold Units” to Study COVID-19 (2020) (4)
- Immunopathogenesis of dengue infection in the rhesus monkey. (1974) (4)
- Dengue fever, viral hemorrhagic fevers, and rabies (1992) (4)
- NS1, Dengue's Dagger. (2019) (4)
- Inquiry into hereditary factors in the pathogenesis of dengue haemorrhagic fever: a preliminary note. (1966) (4)
- Stumbles on the path to dengue control. (2014) (4)
- Tropical Viral Infections * (1998) (4)
- Rubella immunization. Persistence of antibody four years after a large-scale field trial. (1976) (4)
- RUBELLA: REINFECTION OF VACCINATED AND NATURALLY IMMUNE PERSONS EXPOSED IN AN EPIDEMIC (1971) (3)
- Dr. Guzmán et al. Respond to Dr. Vaughn (2000) (3)
- Idiopathic Urinary Bladder Stone Disease: edited by R. Van Reen. xvi + 370 pages, illustrated. Fogarty International Center Proceedings No. 37, DHEW Publication No. (NIH) 77-1063, Washington, D.C. 1977. No price (1978) (3)
- Dengue virus replication in cultures of peripheral blood leukocytes during the course of dengue haemorrhagic fever. (1975) (3)
- Dengue haemorrhagic fever. (1983) (3)
- Diseases of travelers and immigrants (1987) (3)
- Community-based Dengue Control : A Description and Critique of The Rockefeller Foundation Program (1994) (3)
- Survival of Dengue virus in post mortem samples of tissues from experimentally infected Rhesus monkeys. (1973) (3)
- Protective Immune Responses to Dengue Virus Infection and Vaccines: Perspectives from the Field to the Bench (2015) (3)
- Intraepidemic increases in dengue disease severity: applying lessons on surveillance & transmission (2014) (3)
- Evaluation of suckling mice and tissue culture for recovery of viruses from haemorrhagic fever patients in Thailand. (1966) (2)
- 17 – Dengue Vaccines (2018) (2)
- Recovery of Dengue Viruses from Tissues of Experimentally Infected Rhesus Monkeys (1972) (2)
- Response to Hadinegoro et al. (2016) (2)
- Serological studies of dengue haemorrhagic fever. (1966) (2)
- Recovery of dengue and chikungunya viruses from Thai haemorrhagic fever patients by passage in sucking mice. (1966) (2)
- Faculty Opinions recommendation of Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever. (2008) (2)
- Faculty Opinions recommendation of Genetic Variation between Dengue Virus Type 4 Strains Impacts Human Antibody Binding and Neutralization. (2019) (2)
- International infrastructure to control infectious diseases (1991) (2)
- Is Dengue Vaccine Protection Possible? (2021) (2)
- Three commentaries on ‘Corticosteroids for treating dengue shock syndrome’, with introduction by EBCH editor (2007) (2)
- Poliomyelitis in Laos, 1962-1963. Epidemic and immunity survey. (1966) (2)
- Potiskum virus: enhancement of replication in a macrophage-like cell line. (1987) (2)
- Rubella: Reinfection in Vaccines and Natural Immunes Exposed in an Epidemic (1970) (2)
- Arboviral Encephalitis outside North America (2011) (2)
- Identification of dengue and chikungunya viruses. (1966) (2)
- Dengue, yellow fever, and rabies (1994) (2)
- An Urgent Need for "Common Cold Units" to Study Novel Coronavirus Disease (COVID-19). (2020) (2)
- Chikungunya and Zika Disease (2018) (2)
- Immune Enhancement of Viral Infection (Part 3 of 3) (1982) (2)
- Tropical and travel-associated diseases (1996) (2)
- Nosocomial dengue in health-care workers – Author's reply (2008) (1)
- Human factors in emerging infectious diseases (2021) (1)
- Rubella susceptibility among adults in Hawaii: differences by sex and ethnic group. (1970) (1)
- Faculty Opinions recommendation of Determinants of inapparent and symptomatic dengue infection in a prospective study of primary school children in Kamphaeng Phet, Thailand. (2011) (1)
- Faculty Opinions recommendation of Epidemiological factors associated with dengue shock syndrome and mortality in hospitalized dengue patients in Ho Chi Minh City, Vietnam. (2011) (1)
- ANTIGENIC AND BIOLOGICAL CLASSIFICATION OF DENGUE VIRUSES. (1970) (1)
- Vaccines for Japanese encephalitis (1996) (1)
- Children's vaccine initiative ad hoc committee on an investment strategy for measles control (1994) (1)
- Cause and consequence of loss in vaccine trust (2018) (1)
- Faculty Opinions recommendation of Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells. (2013) (1)
- High avidity and potent neutralizing cross-reactive human monoclonal (2013) (1)
- Planning for the Future: the Astmh Council Retreat (1992) (1)
- Faculty Opinions recommendation of Antibodies to envelope glycoprotein of dengue virus during the natural course of infection are predominantly cross-reactive and recognize epitopes containing highly conserved residues at the fusion loop of domain II. (2008) (1)
- " ... and hygiene?" Our once and future mission. (1992) (1)
- Attempts at virus recovery from patients dying of Thai haemorrhagic fever. (1966) (1)
- Serologic response to Far East influenza. (1959) (1)
- Safety of live-attenuated Japanese encephalitis (JE) vaccine (SA14-14-2) (1997) (1)
- A mathematical model for the control of dengue using vaccines (2012) (1)
- Other Viral Hemorrhagic Fevers (2011) (1)
- Faculty Opinions recommendation of Spatial and temporal clustering of dengue virus transmission in Thai villages. (2009) (1)
- Faculty Opinions recommendation of Sonographic findings of healthy volunteers infected with dengue virus. (2008) (0)
- Prospects for Vaccines to Prevent Dengue (2016) (0)
- Faculty Opinions recommendation of OSBPL10, RXRA and lipid metabolism confer African-ancestry protection against dengue haemorrhagic fever in admixed Cubans. (2019) (0)
- The fi ght against rabies : the Middle East needs to step up its game (2016) (0)
- Faculty Opinions recommendation of Vaccine-mediated immunity against dengue and the potential for long-term protection against disease. (2014) (0)
- Immunity in Dengue (1983) (0)
- Faculty Opinions recommendation of Viral genetic diversity and protective efficacy of a tetravalent dengue vaccine in two phase 3 trials. (2019) (0)
- Faculty Opinions recommendation of Genetic epidemiology of dengue viruses in phase III trials of the CYD tetravalent dengue vaccine and implications for efficacy. (2019) (0)
- Introduction to the Soper Lecture (1986) (0)
- Faculty Opinions recommendation of Protective versus pathologic pre-exposure cytokine profiles in dengue virus infection. (2019) (0)
- Faculty Opinions recommendation of Nationally-representative serostudy of dengue in Bangladesh allows generalizable disease burden estimates. (2019) (0)
- DENGUE AND JAPANESE ENCEPHALITIS (1996) (0)
- Faculty Opinions recommendation of Contributions from the silent majority dominate dengue virus transmission. (2019) (0)
- Faculty Opinions recommendation of Interference and facilitation between dengue serotypes in a tetravalent live dengue virus vaccine candidate. (2011) (0)
- Book Review Virus X: Tracking the new killer plagues; Out of the present and into the future By Frank Ryan. 430 pp., illustrated. Boston, Little, Brown, 1997. $24.95. 0-316-76383-7 (1997) (0)
- Faculty Opinions recommendation of Antibodies targeting dengue virus envelope domain III are not required for serotype-specific protection or prevention of enhancement in vivo. (2012) (0)
- Comments on “Dengue management in triage using ultrasound in children from Cambodia: A prospective cohort study” (2022) (0)
- Faculty Opinions recommendation of Clinical and laboratory characteristics and risk factors for fatality in elderly patients with dengue hemorrhagic fever. (2009) (0)
- [The system of international control of infectious diseases]. (1991) (0)
- Rabies and viral hemorrhagic fevers (1991) (0)
- Faculty Opinions recommendation of Effect of dengue serostatus on dengue vaccine safety and efficacy. (2018) (0)
- Faculty of 1000 evaluation for Human dengue virus serotype 2 neutralizing antibodies target two distinct quaternary epitopes. (2018) (0)
- Dengue vaccine development: II. problems to be solved (2015) (0)
- Epidemiology and health in Thailand. (1972) (0)
- Arboviral Encephalitis in North America (2011) (0)
- Of cytokines and things (1998) (0)
- Faculty Opinions recommendation of A potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface. (2014) (0)
- Reproductive Immunology News * (1982) (0)
- Faculty Opinions recommendation of C-reactive protein as a potential biomarker for disease progression in dengue: a multi-country observational study. (2020) (0)
- Children's vaccine initiative. (1992) (0)
- Faculty Opinions recommendation of Timing of CD8+ T cell responses in relation to commencement of capillary leakage in children with dengue. (2010) (0)
- Emerging and endangered infections (2001) (0)
- Faculty Opinions recommendation of Mapping the human memory B cell and serum neutralizing antibody responses to dengue virus serotype 4 infection and vaccination. (2019) (0)
- Correspondence Measuring Dengue Enhancing Antibodies: Caveats (2006) (0)
- Faculty Opinions recommendation of Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial. (2012) (0)
- Correction (1963) (0)
- Arboviruses and catalase(s). (1970) (0)
- Transfer of Vaccine Production to the Developing World: Rabies Vaccine (1989) (0)
- PIN3 COST-EFFECTIVENESS OF VACCINE DEVELOPMENT AND ENVIRONMENTAL CONTROL AGAINST DENGUE IN SOUTHEAST ASIA (2002) (0)
- 19.熱における補体成分の変動(第5回補体シンポジウム記録) (1969) (0)
- Online Supporting Text S 2 : Parameter selection for the model (2012) (0)
- Faculty Opinions recommendation of Dengue--how best to classify it. (2012) (0)
- Faculty Opinions recommendation of Prior Exposure to Zika Virus Significantly Enhances Peak Dengue-2 Viremia in Rhesus Macaques. (2017) (0)
- Reference health centres. (1993) (0)
- Faculty Opinions recommendation of Development of DENVax: a chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever. (2011) (0)
- Faculty Opinions recommendation of Subversion of early innate antiviral responses during antibody-dependent enhancement of Dengue virus infection induces severe disease in immunocompetent mice. (2015) (0)
- Faculty Opinions recommendation of Slower rates of clearance of viral load and virus-containing immune complexes in patients with dengue hemorrhagic fever. (2007) (0)
- Hantavirus Pulmonary Syndrome (2011) (0)
- Faculty Opinions recommendation of Higher plasma viremia in the febrile phase is associated with adverse dengue outcomes irrespective of infecting serotype or host immune status: an analysis of 5642 vietnamese cases. (2021) (0)
- Faculty Opinions recommendation of Dengue type 1 viruses circulating in humans are highly infectious and poorly neutralized by human antibodies. (2018) (0)
- Faculty Opinions recommendation of Choice of fluids for resuscitation in children with severe infection and shock: systematic review. (2011) (0)
- Dengue: A Water‐Borne Disease (2011) (0)
- Propagation of dengue viruses in murine cell cultures. (1981) (0)
- Faculty Opinions recommendation of Cyclic Dinucleotide-Adjuvanted Dengue Virus Nonstructural 1 Protein Induces Protective Antibody and T Cell Responses. (2019) (0)
- Faculty Opinions recommendation of Impacts of Zika emergence in Latin America on endemic dengue transmission. (2020) (0)
- Faculty Opinions recommendation of Cross-protective immunity can account for the alternating epidemic pattern of dengue virus serotypes circulating in Bangkok. (2007) (0)
- Faculty Opinions recommendation of Analysis of repeat hospital admissions for dengue to estimate the frequency of third or fourth dengue infections resulting in admissions and dengue hemorrhagic fever, and serotype sequences. (2007) (0)
- Faculty Opinions recommendation of Comparison of three fluid solutions for resuscitation in dengue shock syndrome. (2006) (0)
- Nguyen Trong Lan, MD, PhD (2018) (0)
- Faculty Opinions recommendation of Flavivirus NS1 Triggers Tissue-Specific Vascular Endothelial Dysfunction Reflecting Disease Tropism. (2019) (0)
- Faculty Opinions recommendation of Global Assessment of Dengue Virus-Specific CD4+ T Cell Responses in Dengue-Endemic Areas. (2019) (0)
- Faculty Opinions recommendation of Transmission dynamics and epidemiology of dengue: insights from age-stratified sero-prevalence surveys. (2007) (0)
- Interview with Scott B. Halstead, M.D. (2007) (0)
- An epidemiology of bladder stone in Thailand. (1964) (0)
- A Step in the Right Direction. (2020) (0)
- Absence of leukocytes permissive to dengue 2 virus in the acute phase of dengue hemorrhagic fever. (1979) (0)
- Thanks to Reviewers and Sources of Submissions (2017) (0)
- Rabies, viral hemorrhagic fevers and insect-spread diseases (1989) (0)
- Faculty Opinions recommendation of Biased efficacy estimates in phase-III dengue vaccine trials due to heterogeneous exposure and differential detectability of primary infections across trial arms. (2019) (0)
- Faculty Opinions recommendation of Dengue in Vietnamese infants--results of infection-enhancement assays correlate with age-related disease epidemiology, and cellular immune responses correlate with disease severity. (2009) (0)
- The rubella problem in Hawaii. (1969) (0)
- Faculty Opinions recommendation of Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions. (2012) (0)
- Contributors (2008) (0)
- Faculty Opinions recommendation of History of domestication and spread of Aedes aegypti--a review. (2014) (0)
- Faculty Opinions recommendation of An outbreak of primary dengue infection among migrant Chinese workers in Singapore characterized by prominent gastrointestinal symptoms and a high proportion of symptomatic cases. (2006) (0)
- Online Supporting Text S 1 : Dengue transmission model description (2012) (0)
- Dengue vaccine development: l. status (2015) (0)
- Faculty Opinions recommendation of Structural basis for antibody inhibition of flavivirus NS1-triggered endothelial dysfunction. (2021) (0)
- Faculty Opinions recommendation of Analyzing the human serum antibody responses to a live attenuated tetravalent dengue vaccine candidate. (2018) (0)
- Faculty Opinions recommendation of Depressive and Anxiety Symptoms among Pediatric In-Patients with Dengue Fever: A Case-Control Study. (2020) (0)
- Letter from Nepalgunj. (2000) (0)
- COVID-19: The Need for Immunoprevention at Industrial Scale (2020) (0)
- Faculty Opinions recommendation of Functional Transplant of a Dengue Virus Serotype 3 (DENV3)-Specific Human Monoclonal Antibody Epitope into DENV1. (2016) (0)
- Dengue viral antigen and RNA localization in naturally infected human tissues by immunohistochemistry and in situ hybridization. (2010) (0)
- Faculty of 1000 evaluation for Joint ancestry and association test indicate two distinct pathogenic pathways involved in classical dengue fever and dengue shock syndrome. (2018) (0)
- Faculty Opinions recommendation of Hemostatic changes in Vietnamese children with mild dengue correlate with the severity of vascular leakage rather than bleeding. (2009) (0)
- The virtues of epidemiology. (1999) (0)
- Alimentary Hypersensitivity Induced by Giardia Lamblia (2020) (0)
- Immune Enhancement of Viral Infection (Part 2 of 3) (1982) (0)
- Faculty Opinions recommendation of Effects of short-course oral corticosteroid therapy in early dengue infection in Vietnamese patients: a randomized, placebo-controlled trial. (2012) (0)
- Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection (2013) (0)
- Is discussion of dengue vaccination for the 2016 Olympics necessary?: Authors' reply (2016) (0)
- Major General (Ret) Philip King Russell. (2021) (0)
- PIN5 COST-EFFECTIVENESS OF VACCINATING ADULT CLOSE CONTACTS WITH BOOSTRIX® (2010) (0)
- Faculty Opinions recommendation of Sterile-insect methods for control of mosquito-borne diseases: an analysis. (2011) (0)
This paper list is powered by the following services:
Other Resources About Scott Halstead
What Schools Are Affiliated With Scott Halstead?
Scott Halstead is affiliated with the following schools:
